Latest findings · Chronic pain ·
THC:CBD ratio and chronic pain: balanced or high-THC gave small drops; low-THC/high-CBD may not help
Systematic review of 25 RCTs AI-graded ⓘ
AI-graded: the grade and plain-words summary were written by AI from the cited studies; PubMed and DOI links were checked automatically. Not reviewed by a doctor. Always check the source.
In plain words
A 2026 systematic review pooled 25 trials with 2,303 people, mostly using pills and sprays.
Balanced and high-THC products gave small pain drops, about 0.5 to 0.8 points on a 10-point scale, with more dizziness, sedation and nausea.
Low-THC/high-CBD products may not help.
Typical strains
Typically balanced: Harlequin, Pennywise. Check the COA.
Studies (PubMed)
- SRChou et al., Ann Intern Med 2026 PMID 41429020 · DOISystematic review of 25 RCTs (n=2,303). High-THC −0.78, comparable THC:CBD −0.54 pts (0–10); low THC:CBD may not help; more dizziness/sedation/nausea.
Studies suggest; they do not prove. Animal results may not apply to people. Not medical advice; talk to a doctor.
More findings
- Sleep: CBN and sleep: a high dose helped people fall asleep faster, but did not cut night waking
- Anxiety + mood: CBD vs THC for anxiety: CBD and balanced flower groups improved far more than THC-only
- Migraine: THC + CBD flower vs migraine: 67% got relief at 2 hours, vs 47% on placebo
- Inflammation / arthritis: β-caryophyllene and arthritis: it cut swelling in rats, while a THC pill didn't beat placebo for knee pain
- Appetite: CBD and appetite: healthy adults ate 193 kcal more after CBD, without feeling hungrier